Verona Pharma plc (VRNA) has 20 known insider and institutional holders on record. The largest holder is Blavatnik Len with 55,911,648 shares. Other notable holders include Access Industries Holdings LLC and ZACCARDELLI DAVID.
Over the last 12 months, insiders have made 40 transactions in VRNA stock — 16 buys (valued at $431.64K) and 15 sells (valued at $26.87M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
VRNA Insider Ownership
Top Holder
Blavatnik Len
55,911,648 shares
Buys (12 mo)
16
$431.64K value
Sells (12 mo)
15
$26.87M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Blavatnik Len |
Director |
55,911,648 |
2022-08-17 |
|
| 2 |
Access Industries Holdings Llc |
10 Percent Owner |
51,111,648 |
2022-08-17 |
|
| 3 |
Zaccardelli David |
President and CEO |
13,190,168 |
2025-06-13 |
|
| 4 |
Hahn Mark W |
Chief Financial Officer |
12,278,992 |
2025-06-13 |
|
| 5 |
Makower Joshua |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 6 |
Sonsini Peter W. |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 7 |
Makhzoumi Mohamad |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 8 |
Sandell Scott D |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 9 |
Baskett Forest |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 10 |
Florence Anthony A. Jr. |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 11 |
Gupta Rishi |
Director |
4,180,691 |
2023-05-15 |
|
| 12 |
Orbimed Advisors Llc |
Director |
4,180,691 |
2023-05-15 |
|
| 13 |
Rickard Kathleen A. |
Chief Medical Officer |
2,546,472 |
2025-05-08 |
|
| 14 |
Poll Claire |
General Counsel |
1,176,920 |
2024-02-05 |
|
| 15 |
Fisher Andrew |
General Counsel |
439,999 |
2025-06-18 |
|
| 16 |
Austwick Michael |
Director |
96,000 |
2025-04-29 |
|
| 17 |
Deschamps Lisa |
Director |
96,000 |
2025-04-29 |
|
| 18 |
Shah Mahendra |
Director |
96,000 |
2025-04-29 |
|
| 19 |
Edwards Martin |
Director |
96,000 |
2025-04-29 |
|
| 20 |
Cunningham Kenneth |
Director |
96,000 |
2025-04-29 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2025-06-16 |
Fisher Andrew |
General Counsel |
Informative Sell |
80,000 |
$11.53 |
$922K |
| 2025-05-15 |
Fisher Andrew |
General Counsel |
Option Exercise |
80,000 |
$2.01 |
$160.9K |
| 2025-06-11 |
Zaccardelli David |
President and CEO |
Informative Sell |
400,000 |
$11.40 |
$4.56M |
| 2025-06-11 |
Hahn Mark W |
Chief Financial Officer |
Informative Sell |
400,000 |
$11.40 |
$4.56M |
| 2025-05-29 |
Zaccardelli David |
President and CEO |
Informative Sell |
208,696 |
$9.33 |
$1.95M |
| 2025-05-28 |
Zaccardelli David |
President and CEO |
Informative Sell |
157,704 |
$9.30 |
$1.47M |
| 2025-05-27 |
Zaccardelli David |
President and CEO |
Informative Sell |
33,600 |
$9.53 |
$320.18K |
| 2025-05-29 |
Hahn Mark W |
Chief Financial Officer |
Informative Sell |
204,864 |
$9.33 |
$1.91M |
| 2025-05-28 |
Hahn Mark W |
Chief Financial Officer |
Informative Sell |
162,704 |
$9.30 |
$1.51M |
| 2025-05-27 |
Hahn Mark W |
Chief Financial Officer |
Informative Sell |
32,432 |
$9.53 |
$308.98K |
| 2025-05-20 |
Sinha Vikas |
Director |
Option Exercise (Sell) |
160,000 |
$0.50 |
$80.61K |
| 2025-04-29 |
Sinha Vikas |
Director |
Option Exercise (Sell) |
120,384 |
$1.70 |
$204.65K |
| 2025-05-15 |
Fisher Andrew |
General Counsel |
Informative Sell |
80,000 |
$8.57 |
$685.6K |
| 2025-05-14 |
Ackermann Christina |
Director |
Informative Sell |
40,000 |
$8.44 |
$337.6K |
| 2025-05-06 |
Rickard Kathleen A. |
Chief Medical Officer |
Informative Sell |
114,984 |
$8.82 |
$1.01M |
| 2025-05-01 |
Rickard Kathleen A. |
Chief Medical Officer |
Option Exercise (Sell) |
50,000 |
- |
- |
| 2025-05-02 |
Zaccardelli David |
President and CEO |
Informative Sell |
400,000 |
$9.09 |
$3.64M |
| 2025-05-01 |
Zaccardelli David |
President and CEO |
Option Exercise (Sell) |
200,000 |
- |
- |
| 2025-05-02 |
Hahn Mark W |
Chief Financial Officer |
Informative Sell |
400,000 |
$9.09 |
$3.64M |
| 2025-05-01 |
Hahn Mark W |
Chief Financial Officer |
Option Exercise (Sell) |
200,000 |
- |
- |
| 2025-05-01 |
Ebsworth David R |
Director |
Option Exercise |
140,000 |
$1.93 |
$270.73K |
| 2025-04-29 |
Fisher Andrew |
General Counsel |
Option Exercise (Sell) |
86,064 |
- |
- |
| 2025-03-19 |
Fisher Andrew |
General Counsel |
Gift (Received) |
1 |
- |
- |
| 2025-04-29 |
Rickard Kathleen A. |
Chief Medical Officer |
Option Exercise (Sell) |
86,064 |
- |
- |
| 2024-08-07 |
Rickard Kathleen A. |
Chief Medical Officer |
RSU Award |
300,000 |
- |
- |
